English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 848884 Online Users : 1401
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
癌症研究所
于重元
劉柯俊
劉滄梧
劉界元(2003-2010)
夏和雄(1996-2012)
夏興國
姜乃榕
常慧如
張俊彥
張光裕
張憶壽
張文祥
張書銘
彭汪嘉康(1996-2007)
施能耀
李家惠
李岳倫
林素芳
楊奕馨
江士昇
沈哲宏
洪文俊
莊雙恩
蔡坤志
蔡慧珍
蘇勇曄
蘇振良
郭靜娟
陳尚鴻
陳振陽
陳立宗
陳美霞(2002-2009)
陳詩政
陳雅雯
黃智興
黃道揚
丁兆治(2000-2004)
其他
劉敏(1996-2007)
劉玫英(2004-2006)
吳成文(1996-2008)
曾思文(1997-2007)
李冠德(1997-2004)
林景太(1999-2007)
楊文光(1996-1999)
王全正(1996-2003)
莊聲宏(1997-2004)
詹宗晃(2000-2008)
賴基銘(2004-2008)
阮麗蓉(2000-2006)
陳俊叡(2003-2007)
馬彥英(1997-1999)
黃奇英(2005-2007)
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
癌症研究所
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Sub-Community
于重元
[
19
/19]
劉柯俊
[
85
/98]
劉滄梧
[
119
/125]
劉界元(2003-2010)
[
3
/3]
夏和雄(1996-2012)
[
26
/31]
夏興國
[
51
/54]
姜乃榕
[
82
/94]
常慧如
[
39
/44]
張俊彥
[
234
/254]
張光裕
[
69
/79]
張憶壽
[
103
/106]
張文祥
[
52
/53]
張書銘
[
89
/91]
彭汪嘉康(1996-2007)
[
120
/126]
施能耀
[
37
/43]
李家惠
[
29
/29]
李岳倫
[
48
/49]
林素芳
[
32
/32]
楊奕馨
[
41
/42]
江士昇
[
88
/90]
沈哲宏
[
14
/16]
洪文俊
[
88
/88]
莊雙恩
[
82
/91]
蔡坤志
[
32
/34]
蔡慧珍
[
66
/71]
蘇勇曄
[
40
/40]
蘇振良
[
24
/25]
郭靜娟
[
71
/76]
陳尚鴻
[
45
/48]
陳振陽
[
72
/72]
陳立宗
[
443
/510]
陳美霞(2002-2009)
[
1
/1]
陳詩政
[
2
/2]
陳雅雯
[
38
/39]
黃智興
[
55
/55]
黃道揚
[
26
/26]
丁兆治(2000-2004)
[
5
/5]
其他
[
464
/471]
劉敏(1996-2007)
[
60
/62]
劉玫英(2004-2006)
[
2
/2]
吳成文(1996-2008)
[
53
/55]
曾思文(1997-2007)
[
4
/4]
李冠德(1997-2004)
[
4
/6]
林景太(1999-2007)
[
5
/5]
楊文光(1996-1999)
[
21
/21]
王全正(1996-2003)
[
4
/4]
莊聲宏(1997-2004)
[
11
/11]
詹宗晃(2000-2008)
[
2
/2]
賴基銘(2004-2008)
[
41
/47]
阮麗蓉(2000-2006)
[
6
/7]
陳俊叡(2003-2007)
[
6
/6]
馬彥英(1997-1999)
[
1
/1]
黃奇英(2005-2007)
[
9
/10]
Siblings
分子與基因醫學研究所
[
921
/964]
生技與藥物研究所
[
830
/1008]
生醫工程與奈米醫學研究所
[
1214
/1334]
免疫醫學研究中心
[
224
/236]
神經及精神醫學研究中心
[
782
/804]
細胞及系統醫學研究所
[
755
/815]
感染症與疫苗研究所
[
1541
/1618]
群體健康科學研究所
[
2870
/3000]
國家環境醫學研究所
[
1560
/1591]
國家蚊媒傳染病防治研究中心
[
102
/104]
高齡醫學暨健康福祉研究中心
[
216
/224]
論壇
[
2
/2]
生醫資源中心
[
7
/7]
研究生培育合作學程
[
188
/191]
核心儀器設施中心
[
9
/9]
病理核心實驗室
[
14
/14]
實驗動物中心
[
8
/8]
行政管理部門
[
18
/18]
Community Statistics
近3年內發表的文件:335(13.91%)
含全文筆數:2250(93.40%)
文件下載次數統計
下載大於0次:2250(100.00%)
下載大於100次:2250(100.00%)
檔案下載總次數:1606259(29.97%)
最後更新時間: 2024-11-28 06:18
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Pathological response following neo...
Registry of genetic alterations of ...
Activated single nucleotide mismatc...
Taiwan nationwide study of first-li...
The effectiveness of virtual passpo...
Special Issue "Bioinformatics ...
Evaluating a natural language proce...
The clinicopathological significanc...
Hypoxia in drug resistance and radi...
DKK1 as a chemoresistant protein mo...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 176-200 of 2409. (97 Page(s) Totally)
<<
<
3
4
5
6
7
8
9
10
11
12
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2023-03
ASPM activates Hedgehog and Wnt signaling to promote small cell lung cancer stemness and progression
Cancer Research. 2023 Mar 15;83(6):830-844.
2023-02-28
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
Frontiers in Oncology. 2023 Feb 28;13:Article number 1096683.
2023-02-25
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
World Journal of Surgical Oncology. 2023 Feb 25;21(1):Article number 62.
2023-02-24
Deciphering the functions of telomerase reverse transcriptase in head and neck cancer
Biomedicines. 2023 Feb 24;11(3):Article number 691.
2023-02-05
Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer
Cancers. 2023 Feb 5;15(4):Article number 1008.
2023-02-03
MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition
Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
2023-02-01
Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers
Cancer Letters. 2023 Feb 1;554:Article number 216008.
2023-02
A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment
Cancer Immunology Immunotherapy. 2023 Feb;72(2):351-369.
2023-02
ASO visual abstract: Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment
Annals of Surgical Oncology. 2023 Feb;30(2):1182-1183.
2023-02
Distinct failure patterns in hypopharyngeal cancer patients receiving surgery-based versus radiation-based treatment
Annals of Surgical Oncology. 2023 Feb;30(2):1169-1181.
2023-02
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan
ESMO Open. 2023 Feb;8(1):Article number 100746.
2023-02
Augmenting DSM-5 diagnostic criteria with self-attention-based BiLSTM models for psychiatric diagnosis
Artificial Intelligence in Medicine. 2023 Feb;136:Article number 102488.
2023-02
Deep-learning based breast cancer detection for cross-staining histopathology images
Heliyon. 2023 Feb;9(2):Article number e13171.
2023-01-30
Real-world effectiveness of sorafenib versus lenvatinib combined with PD-1 inhibitors in unresectable hepatocellular carcinoma
Cancers. 2023 Jan 30;15(3):Article number 854.
2023-01-27
The biological impacts of CEBPD on urothelial carcinoma development and progression
Frontiers in Oncology. 2023 Jan 27;13:Article number 1123776.
2023-01-21
Adjuvant therapy in biliary tract cancers: Oral fluoropyrimidine as a beginning
Lancet. 2023 Jan 21-27;401(10372):170-171.
2023-01-20
ARID1A loss in pancreas leads to islet developmental defect and metabolic disturbance
iScience. 2023 Jan 20;26(1):Article number 105881.
2023-01-19
Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma
New England Journal of Medicine. 2023 Jan 19;388(3):228-239.
2023-01-19
Actin-like protein 6A expression correlates with cancer stem cell-like features and poor prognosis in ovarian cancer
International Journal of Molecular Sciences. 2023 Jan 19;24(3):Article number 2016.
2023-01-06
Visible CCD camera-guided photoacoustic imaging system for precise navigation during functional rat brain imaging
Biosensors. 2023 Jan 6;13(1):Article number 107.
2023-01
TRPM1 promotes tumor progression in acral melanoma by activating the Ca2+/CaMKIIdelta/AKT pathway
Journal of Advanced Research. 2023 Jan;43:45-57.
2023-01
Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway
Cancer Medicine. 2023 Jan;12(2):1588-1601.
2023-01
A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer
Neoplasia. 2023 Jan;35:Article number 100856.
2022-12-31
Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019
Viruses. 2022 Dec 31;15(1):Article number 126.
2022-12-28
Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan
Scientific Reports. 2022 Dec 28;12:Article number 22492.
Showing items 176-200 of 2409. (97 Page(s) Totally)
<<
<
3
4
5
6
7
8
9
10
11
12
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback